Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission.

Tanya L Daigle, Mark J Ferris, Raul R Gainetdinov, Tatyana D Sotnikova, Nikhil M Urs, Sara R Jones, Marc G Caron

Index: Neuropsychopharmacology 39(10) , 2450-62, (2014)

Full Text: HTML

Abstract

GRK2 is a G protein-coupled receptor kinase (GRK) that is broadly expressed and is known to regulate diverse types of receptors. GRK2 null animals exhibit embryonic lethality due to a severe developmental heart defect, which has precluded the study of this kinase in the adult brain. To elucidate the specific role of GRK2 in the brain dopamine (DA) system, we used a conditional gene knockout approach to selectively delete GRK2 in DA D1 receptor (D1R)-, DA D2 receptor (D2R)-, adenosine 2A receptor (A2AR)-, or DA transporter (DAT)-expressing neurons. Here we show that select GRK2-deficient mice display hyperactivity, hyposensitivity, or hypersensitivity to the psychomotor effects of cocaine, altered striatal signaling, and DA release and uptake. Mice with GRK2 deficiency in D2R-expressing neurons also exhibited increased D2 autoreceptor activity. These findings reveal a cell-type-specific role for GRK2 in the regulation of normal motor behavior, sensitivity to psychostimulants, dopamine neurotransmission, and D2 autoreceptor function.


Related Compounds

  • Formaldehyde
  • Cocaine
  • R-(-)-Apomorphine

Related Articles:

ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling.

2015-01-01

[Nat. Commun. 6 , 5794, (2015)]

Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.

2015-05-01

[Biomaterials 51 , 1-11, (2015)]

BBS4 directly affects proliferation and differentiation of adipocytes.

2014-09-01

[Cell. Mol. Life Sci. 71(17) , 3381-92, (2014)]

Co-ordinated brain and craniofacial development depend upon Patched1/XIAP regulation of cell survival.

2015-02-01

[Hum. Mol. Genet. 24(3) , 698-713, (2015)]

The CAP1/Prss8 catalytic triad is not involved in PAR2 activation and protease nexin-1 (PN-1) inhibition.

2014-11-01

[FASEB J. 28(11) , 4792-805, (2014)]

More Articles...